Michael G. Palfreyman
Company: Palfreyman BioPharm Advisors
Job title: President
Seminars:
Unlocking the Potential of Nasal Delivery of Psychedelics for Enhanced Therapeutic Impact 3:00 pm
Amplifying potency with intranasal delivery of psychedelics, exemplified by 5-methoxyDMT, and exploring its advantages, including high cellular penetration and avoiding the first-pass metabolism Investigating the potential of single-use nasal administration to accelerate speed of onset, ease of self-administration, increasing safety and accessibility for psychiatric patients and on the field during combat Delving into the emerging…Read more
day: Conference Day Two
Chair’s Opening Remarks 8:45 am
day: Conference Day Two
Synergizing Formulation Strategy with Devices for Nasal Drug Delivery 11:45 am
Nasal drug-device compatibility can be challenging due to a combination of physiological, technical, and formulation-related factors. Join us as we explore key topics, from deposition patterns to data-driven design approaches, and unlock the secrets to precise dosing accuracy in nasal drug delivery. Take part in this workshop as we explore: Reviewing formulation considerations with deposition…Read more
day: Pre-Conference Day